The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 601–700 of 744
Precision Engineering of Extracellular Vesicles as Programmable Carriers for mRNA Therapeutics
Yoon, H., Lee, G., Jo, J., Koo, J., Kim, E., Choi, H. J., Jung, S., Shin, Y., Oh, K. T., & Lim, C. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s595161 · Cited by 3
AI-nanotech synergies: recent advances in sustainable bio-manufacturing
Sharma, P., & Singh, S. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-05067-w · Cited by 3
Gao, M., Yin, Q., Zhong, Z., Song, Z., Song, X., Zhao, R., Wen, H. L., He, F., Zhang, M., & Pang, Q. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04710-w · Cited by 3
Bingxue, D., Wenchao, L., & Xing, B. (2022) · Springer eBooks · doi:10.1007/978-981-16-1313-5_74-1 · Cited by 3
Exosomes and Their Application as Drug Delivery System in Cancer Therapy
Yang, K., MA, B., Yu, T., LI, K., Zhang, L., YUAN, X., ZHANG, H., Yan, Z., & Chen, T. (2024) · Acta Poloniae Pharmaceutica - Drug Research · doi:10.32383/appdr/183063 · Cited by 3
Mammalian Cell Membrane Hybrid Polymersomes for mRNA Delivery
Shin, S., Ahn, Y., Kim, M., Choi, J., Kim, H., & Kim, H. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c00843 · Cited by 3
The roles of extracellular vesicles in gliomas: Challenge or opportunity?
Huang, L., Zhan, J., Li, Y., Huang, K., Zhu, X., & Li, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123150 · Cited by 3
Targeted Tumor Delivery Using Extracellular Vesicles
Ilamathi, H. S., Andaloussi, S. E., & Wiklander, O. P. B. (2025) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-4374-7_7 · Cited by 3
Interoception, heart failure and exosomal cargo as potential biomarkers
Vemuri, S. R., Singh, M., Homme, R. P., & Tyagi, S. C. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101849 · Cited by 3
Liu, F., Sun, H. H., Liu, B., Zhang, J., Wu, C., Yan, S., Tai, C., Tong, Y., Su, R., Xiang, X., et al. (2025) · Advanced Science · doi:10.1002/advs.202507684 · Cited by 3
Self-citationRal GTPases promote metastasis by controlling biogenesis and organ colonization of exosomesPreprint
Ghoroghi, S., Mary, B., Larnicol, A., Klein, A., Osmani, N., Busnelli, I., Delalande, F., Paul, N., Halary, S., Gros, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.10.196691 · Cited by 3
Bone-targeted extracellular vesicles from mesenchymal stem cells for osteoporosis therapyPreprint
Wang, Y., Yao, J., Cai, L., Liu, T., Wang, X., Zhang, Y., Zhou, Z., Li, T., Liu, M., Lai, R., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-18279/v1 · Cited by 3
Self-citationNon-Thermal Liver Ablation: Existing and New Technology
Nakla, T., Chow, J. J., Pham, K. P., & Abi‐Jaoudeh, N. (2023) · Seminars in Interventional Radiology · doi:10.1055/s-0043-1777844 · Cited by 2
Evolution of glioma exosome research: emerging trends and global collaborations (2005–2025)
Zeng, Y., Liu, T., Jing, S., Wang, Y., He, J., Cao, H., Liu, X., & Zhang, L. (2025) · Discover Oncology · doi:10.1007/s12672-025-03167-x · Cited by 2
Self-citationMastoli, S. Y., Saraf, S. A., & Dey, A. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147854 · Cited by 3
Xiang, D., & Nie, Z. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.104016 · Cited by 2
Extracellular vesicles in neurological disorders: emerging roles and underlying molecular mechanisms
Mimi, M. A., & Hasan, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006118 · Cited by 2
RetractedZhou, Y., Ding, D., Liu, F., & Han, F. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s570068 · Cited by 2
Liu, F., Xia, C., Yu, H., Yang, X., Ge, L., & Ye, C. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100473 · Cited by 4
Zhang, M., Pan, X., Li, J., & Wang, H. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112358 · Cited by 2
Zhang, J., Zhao, W., Yu, Y., Yang, M., Li, Y., & Yu, Z. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.172800 · Cited by 2
Chen, Z., Wu, M., Wang, X., & Liang, W. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151033 · Cited by 2
Self-citationZeng, L., Shu, J., Zhong, S., Dong, X., Wu, Y., & Huang, X. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.037 · Cited by 2
Expanding the Microbial Genomic Landscape and Biotechnological Applications of CRISPR-Cas Systems
Singh, S., Tiwari, H., Singh, M., Gautam, V., Gautam, A., & Gautam, H. K. (2026) · Biology · doi:10.3390/biology15100748 · Cited by 2
Engineered Extracellular Vesicles: Advancing Cancer Therapy Through Precision Nanomedicine
Ma, S., Niu, Y., Sui, S., Xu, W., Kong, L., Wu, X., Wu, J., Gao, Y., & Yan, T. (2026) · BIO Integration · doi:10.15212/bioi-2025-0208 · Cited by 2
Nanotechnology-mediated precision delivery of mRNA
Deng, H., Li, L., Zhao, C., Wang, Z., Xiao, Y., Huang, P., Siegwart, D. J., & Chen, X. S. (2026) · Nature Materials · doi:10.1038/s41563-026-02623-5 · Cited by 6
Engineered extracellular vesicles and cancer therapy
Liao, S., Yan, Z., Zhao, W., & Li, N. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0451 · Cited by 2
Kanada, M., Walker, J. C., & Ashammakhi, N. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90792-7.00003-8 · Cited by 2
Review on nucleic acid nanodelivery systems for inflammatory diseases
Guo, M., Guo, Z., Lai, L., Du, X., & Du, B. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105987 · Cited by 2
Klimová, D., Pastorakova, A., Tomka, M., Altaner, Č., & Repiská, V. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105999 · Cited by 2
mRNA vaccine delivery strategies for cancer therapy
Zhang, H., Zhang, H., Xu, B., & Liu, H. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0670 · Cited by 2
Technologies for EV Surface Modification and its Application in Targeted Therapy
Geng, M., Chang, Y., & Li, Z. (2024) · Springer eBooks · doi:10.1007/978-981-97-5536-3_5 · Cited by 2
Acosta-Montaño, P., Félix, E. O., Flores, V. C., García, A. H., Cadena-Nava, R. D., Galindo‐Hernández, O., Juárez, P., & Fournier, P. G. J. (2024) · Biology · doi:10.3390/biology13121066 · Cited by 2
Sun, J., Li, T., Cui, J., Zhang, L., Wang, G., Ma, C., Zhang, C., & Wang, Y. (2025) · Oncogene · doi:10.1038/s41388-025-03356-6 · Cited by 2
Self-citationTowards Extracellular Vesicles in the Treatment of Epidermolysis Bullosa
Sandoval, A. G. W., & Badiavas, E. V. (2025) · Bioengineering · doi:10.3390/bioengineering12060574 · Cited by 2
Nanovesicles for intravenous drug delivery
Gülteki̇n, H. E., Öner, E., İlhan, M., & Karpuz, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00018-3 · Cited by 2
Lin, J., Ning, T., Jia, S.-C., Li, K., Huang, Y., Liu, Q., Lin, J., & Zhang, X. (2024) · World Journal of Stem Cells · doi:10.4252/wjsc.v16.i3.305 · Cited by 2
Machado, C. M. L., Skubal, M., Haedicke, K., Pittella-Silva, F., Stater, E. P., Silva, T. L. A. D. O., Costa, É. T., Masotti, C., Otake, A. H., Andrade, L. N. D. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.482024 · Cited by 2
Extracellular vesicles for remote brain repair
Momma, S. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.06.001 · Cited by 1
Gene Therapy of Extracellular Vesicles in Cardiovascular and Metabolic Diseases
Kovács, Á. F. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-1443-2_14 · Cited by 1
Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment
Yan, W., Cao, Y., Yin, Q., & Li, Y. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081028 · Cited by 1
Kim, H., Song, C., Min, D., Yoo, J., & Choi, J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135416 · Cited by 1
Lehrich, B. M., Liang, Y., & Fiandaca, M. S. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_4 · Cited by 1
Paritala, V., Kalva, S., & Shagamreddy, R. R. (2024) · American Journal of Biopharmacy and Pharmaceutical Sciences · doi:10.25259/ajbps_13_2024 · Cited by 1
Tian, M., Yi, S., Zhao, L., Li, L., Fang, L., & Ru, Q. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100035 · Cited by 1
Ma, Z., Li, Y., Zhu, J., Qiu, S., Chen, Y., Cao, H., Yang, S., Jia, X., Huo, L., Shi, Q., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101980 · Cited by 1
Self-citationNew Advances in Stem Cell–Derived Extracellular Vesicle Functionalization Technology
Tomasini, S., Centomo, M. L., Neveux, I., & Panella, R. (2025) · Stem cells in clinical applications · doi:10.1007/978-3-031-90698-5_6 · Cited by 1
Cao, Y., Meng, X., Xu, X., Xia, C., Yang, C., Cui, X., He, Q., & Song, G. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01828 · Cited by 1
Extracellular vesicles are key mediators for direct antigen transport to draining lymph nodes
Wang, C., Cheng, X., Cheng, K., & Yuan, F. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.034 · Cited by 1
Wang, J., Ran, B., & Wei, J. (2025) · Cureus · doi:10.7759/cureus.97119 · Cited by 2
Research progress of LNP-based mRNA delivery system in the treatment of liver disease
Wang, R., Tian, C., Ji, E., Wu, Q., Wang, J., & Xu, T. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.112138 · Cited by 1
Li, Y., Hua, Y., Wang, Y., Qiao, H., Lin, S., Liu, Y., Zhou, M., & Jiang, X. (2025) · Materials Today Communications · doi:10.1016/j.mtcomm.2025.114386 · Cited by 2
Self-citationChinese herbal medicine-derived nanovesicles for combatting cancers
Guan, B., Zhang, S., Wei, Y., Jian, J., Li, C., Wang, Z., Qu, H., Li, Z., Liu, M., & Wang, J. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102888 · Cited by 1
Exosomes loaded with metabolites: Roles in crosstalk between tumor cells and their microenvironment
Ye, P., Sun, M., Wang, J., Bai, X., Li, Z., Lin, Q., & Liu, R. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178510 · Cited by 1
Chiabotto, G., Conte, M., & Cauda, V. (2025) · Cancers · doi:10.3390/cancers18010118 · Cited by 1
Lin, Y. H., Luo, W., Zhu, X., Yu, J., Li, X., & Xie, L. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.18 · Cited by 2
Liu, H., Wu, Y., Wang, Q., Zhang, T., Tong, X., Yan, F., & Zhang, Q. (2026) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70267 · Cited by 1
Moradi, Z., Khezrian, A., Samavati, A., Amini, R., Boroujeni, A. K., Rostami, H., & Shojaeian, A. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2668709 · Cited by 1
Qu, T. F., Li, Z. J., Zhang, M. M., & Lu, K. K. (2026) · Discover Nano · doi:10.1186/s11671-026-04627-1 · Cited by 1
Khan, N. H., Bushra, M. A., Selina, F. A., & Arbab, A. S. (2026) · Cancers · doi:10.3390/cancers18121923 · Cited by 3
Biomaterials for Treatments of Neurodegenerative Disorders
Yu, Y. P., & Ding, J. (2026) · Engineering · doi:10.1016/j.eng.2026.06.006 · Cited by 1
Johnston, J., Boyce, E., Zanon, T. T. M., Jeon, H., Khong, C., Choi, Y. Y., Myung, N. V., Nunez, M., Pinkstaff, M.-L., & Wang, Y. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.07.005 · Cited by 1
Self-citationMedical Use of mRNA-Based Directed Gene Delivery
Matin, A., & Forterre, A. V. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_5 · Cited by 1
Advances in mRNA Delivery and Clinical Applications
Hu, B., Hussain, A., Liu, Q. L., Weng, Y., & Huang, Y. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_13 · Cited by 1
Defois, A., Bon, N., Charpentier, A., Georget, M., Blanchard, F., Hamel, A., Waast, D., Armengaud, J., Renoult, O., Pecqueur, C., et al. (2023) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2023.01.405 · Cited by 1
Additional Gene Therapeutic Platforms
Langel, Ü. (2023) · Springer eBooks · doi:10.1007/978-3-031-38731-9_6 · Cited by 1
Wang, Y., Zhang, M., Li, G., Hou, T., Li, Z., Chen, S., Wang, D., & Jiang, W. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2023-1077 · Cited by 2
Self-citationOh, S. W., Han, J., & Park, S. (2024) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2024.16 · Cited by 1
Güldiken, İ. N., Eyüboğlu, T. F., & Özcan, M. (2025) · Current Oral Health Reports · doi:10.1007/s40496-025-00403-9 · Cited by 1
Opportunities and Challenges of Biomaterials in Brain Disease
Zheng, W., Jiang, M., Dong, N., Fang, H., Tian, H., & Chen, X. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500746 · Cited by 2
Comparación de dos fármacos biológicos (ustekinumab y etanercept) en el tratamiento de la psoriasis
Griffiths, C. E. M., Strober, B. E., van de Kerkhof, P. C. M., & Abad‐Santos, F. (2010) · Actualidad en farmacología y terapéutica
Anastassakis, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-10613-2_43
Bingxue, D., Wenchao, L., & Xing, B. (2023) · Springer eBooks · doi:10.1007/978-981-16-1313-5_74-2
Bingxue, D., Wenchao, L., & Xing, B. (2023) · Springer eBooks · doi:10.1007/978-981-19-9776-1_74
mRNA Epi-Drugs: The Possible Use and Potential of mRNA in Radiation Therapy
Cattaneo, C. G., & Felice, F. D. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.07.041
Methods for Analysis of Extracellular Vesicle Functions
Yue, S., Wang, H., Zhao, K., Mu, W., & Wang, Z. (2024) · Springer eBooks · doi:10.1007/978-981-99-8365-0_13
Research progress of natural cell-derived nanoparticles in immunotherapy
Dai, H., & Wang, C. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1008
Current applications of new generations of exosomes nanovesicles
Sharma, D., Mudgal, R., Arora, S., & Gugulothu, D. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29052-7.00017-9
Quality control, minimizing heterogeneity and enhancing yield in exosome isolation and production
Mokati, A. S., Uppal, L., Naemoddin, P. M., & Jindal, A. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29052-7.00006-4
Introduction: History and development of exosomes nanovesicles
Arora, S., & Gugulothu, D. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-29052-7.00001-5
Advanced Drug Delivery TechnologiesPreprint
Çetin, E. Ö., Erisik, D., TAŞKIRAN, A., Çalışkan, E. E., Demirtürk, E., AYDIN, Y. Ç., & Uyanıkgil, Y. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5080254
Nanomaterial-Based Drug Delivery System in Targeting Inflammatory Disorders
Kumar, S. S., Ghuge, A., & Gupta, I. R. (2025) · Smart nanomaterials technology · doi:10.1007/978-981-96-2112-5_7
Clinical Applications of Exosomes
Huang, C. F. (2025) · Springer eBooks · doi:10.1007/978-981-96-1261-1_23
Huang, S., Chen, L., Sun, C., Zhang, J., Chen, T., Cao, Y., Song, Q., Xu, X., Zhang, J., Tan, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.25.661423
Polymeric nanoparticle-loaded extracellular vesicles as biomimetic nucleic acid vaccinesPreprint
Fornaguera, C., Alarcón, J. F., Masoero, A., Pagnotta, I., Vaya, R., Castells-Colldeforns, P., Losada, M., Guarro, M., Lecina, M., Sitia, G., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7030394/v1
MODERN CONCEPTS FOR ANTITUMOR VACCINE DESIGN
Frantsiyants, E. M., Bandovkina, V. A., Neskubina, I. V., Menshenina, A. P., Surikova, E. I., & Moiseenko, T. (2025) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2025-3-60-85
Bee venom promotes exosome secretion and alters miRNA cargo in T cells
Cui, Z., Zhou, Z., Sun, Z., Duan, J.-Y., Liu, R., Qi, C., & Yan, C. (2025) · Open Life Sciences · doi:10.1515/biol-2025-1180
Sun, M., Yu, L., Bai, L., Liu, X., Xiong, Y., Zhao, X., Zhong, X., Ran, M., Wang, Y., Yan, X., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111948
Self-citationZhao, Y., Xie, W.-L., Liu, Y., He, J., Chen, J., & Wang, F. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.045
Self-citationHuang, C., Liu, Z., Chen, M., Du, L., Liu, C., Wang, S., Zheng, Y., & Liu, W. (2021) · Figshare · doi:10.6084/m9.figshare.17701607
Yang, Z., Yang, Y., Xu, Y., Jiang, W., Shao, Y., Xing, J., Chen, Y., & Han, Y. (2021) · Figshare · doi:10.6084/m9.figshare.15128597
Self-citationChen, L., Qu, J., Mei, Q., Chen, X., Fang, Y., Chen, L., Li, Y., & Xiang, C. (2021) · Figshare · doi:10.6084/m9.figshare.15102615
Chen, S.-Y., Chen, Y.-L., Li, P.-C., Cheng, T.-S., Chu, Y., Shen, Y.-S., Chen, H.-T., Tsai, W.-N., Huang, C.-L., Sieber, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25434214
Self-citationDefois, A., Bon, N., Charpentier, A., Georget, M., Gaigeard, N., Blanchard, F., Hamel, A., Waast, D., Armengaud, J., Renoult, O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26597195
Cai, H., Pang, Y., Ren, Z., Fu, X., & Jia, L. (2024) · Figshare · doi:10.6084/m9.figshare.25478748
Defois, A., Bon, N., Charpentier, A., Georget, M., Gaigeard, N., Blanchard, F., Hamel, A., Waast, D., Armengaud, J., Renoult, O., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26597192
Cai, H., Pang, Y., Ren, Z., Fu, X., & Jia, L. (2024) · Figshare · doi:10.6084/m9.figshare.25479113
Liu, Q., Xue, B., Zhang, Y., Qin, M., Zhu, Z., Wang, Z., Li, H., Fan, S., Su, M., Li, S., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102585
The interplay between exosomal miRNAs and cytokine networks in metabolic diseases
Joshi, R., Verma, K., Kapoor, D. U., Saini, V., & Sharma, S. K. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1731121
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
